Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0JZ8X
|
|||
Former ID |
DCL001049
|
|||
Drug Name |
HGTV43
|
|||
Drug Type |
Antisense drug
|
|||
Indication | Human immunodeficiency virus-1 infection [ICD-11: 1C62; ICD-10: B20-B24] | Phase 2 | [1] | |
Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 279.3] | Phase 1/2 | [2] | ||
Therapeutic Class |
Antisense
|
|||
Company |
Enzo Biochem
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Human immunodeficiency virus Rev messenger RNA (HIV rev mRNA) | Target Info | . | [3] |
Human immunodeficiency virus Tat messenger RNA (HIV tat mRNA) | Target Info | . | [3] | |
Human immunodeficiency virus Trans-activation response element (HIV TAR RNA element) | Target Info | . | [3] |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009588) | |||
REF 3 | Design and development of antisense drugs. Expert Opin. Drug Discov. 2008 3(10):1189-1207. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.